Effectiveness of Dry Needling in Linear Scar Tissue

Launched by IRAN UNIVERSITY OF MEDICAL SCIENCES · Sep 5, 2023

Keywords

ClinConnect Summary

This clinical trial is studying the effectiveness of a treatment called dry needling for people with linear hypertrophic scars. These scars, which usually form after surgery or injury, can lead to complications like stiffness and difficulty moving, making everyday activities tough. Dry needling involves inserting thin needles into specific areas to help improve the flexibility of tight muscles and scar tissue. The goal of this study is to see if this technique can help improve movement and quality of life for those affected by these types of scars.

To be eligible for the trial, participants should be between 20 and 60 years old and have a linear hypertrophic scar that has been present for more than six weeks. They must also be able to move their joints near the scar without restrictions. However, individuals with needle phobia, certain types of scars, skin infections, diabetes, or those taking blood-thinning medications cannot participate. If someone joins the trial, they can expect to receive dry needling treatment and help researchers learn more about how effective this approach can be for managing scar tissue issues.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Linear hypertrophic scar tissue with an age of more than six weeks
• • No restrictions on active and passive joint range of motion near the scar tissue
• • Age between 20 and 60 years
• Exclusion Criteria:
• • Needle phobia
• • Immature scar or keloid scar
• • Skin diseases or infections near the scar tissue
• • Diabetes
• • Fractures that have altered joint mobility
• • Anticoagulant medication use